Literature DB >> 31912016

The Predictive Value of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio in Patients with Recurrent Idiopathic Granulomatous Mastitis.

Ömer Arda Çetinkaya1, Süleyman Utku Çelik1,2, Serdar Gökay Terzioğlu3, Aydan Eroğlu4.   

Abstract

OBJECTIVE: The aim of this study was to investigate the relationship between the inflammatory parameters including neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) and the prognosis of idiopathic granulomatous mastitis (IGM).
MATERIALS AND METHODS: In this retrospective study, a total of 41 patients with IGM who had no malignant disease or inflammatory pathologies were included between January 2010 and December 2017. The patients were divided into two groups according to presence or absence of recurrence. Subsequently, the relationship between patient characteristics, pre- and postoperative NLR and PLR levels and disease recurrence were evaluated.
RESULTS: With a mean follow-up period of 28.4 months, 19.5% of patients were found to have recurrent IGM. Age, body mass index, patient characteristics such as oral contraceptive use, smoking status, and family history, surgical treatment and postoperative NLR, preoperative PLR, and postoperative PLR were not statistically significant between groups. However, only preoperative NLR was significantly associated with a recurrent IGM (p=0.024). Preoperative NLR predicted recurrence with a sensitivity of 62.5% and specificity of 84.8%.
CONCLUSION: These results demonstrated that a high level of NLR was predictive of poor outcome in patients with IGM.
Copyright © 2020 Turkish Federation of Breast Diseases Associations.

Entities:  

Keywords:  Granulomatous mastitis; neutrophils; platelets; ratios

Year:  2020        PMID: 31912016      PMCID: PMC6939709          DOI: 10.5152/ejbh.2019.5187

Source DB:  PubMed          Journal:  Eur J Breast Health


  14 in total

1.  Granulomatous mastitis: is it an autoimmune disease? Diagnostic and therapeutic dilemmas.

Authors:  Leyla Ozel; Aysun Unal; Ethem Unal; Melih Kara; Erdal Erdoğdu; Osman Krand; Pembegül Güneş; Hikmet Karagül; Serdar Demiral; M Izzet Titiz
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Granulomatous mastitis: Presentations, diagnosis, treatment and outcome in 206 patients from the north of Iran.

Authors:  Manouchehr Aghajanzadeh; Rasool Hassanzadeh; Soheila Alizadeh Sefat; Ali Alavi; Hossein Hemmati; Mohammad Sadegh Esmaeili Delshad; Cyrus Emir Alavi; Siamak Rimaz; Siamak Geranmayeh; Mohammad Najafi Ashtiani; Seyed Mahmoud Habibzadeh; Khosheh Rasam; Sara Massahniya
Journal:  Breast       Date:  2015-04-29       Impact factor: 4.380

3.  Management of Patients with Granulomatous Mastitis: Analysis of 31 Cases.

Authors:  Munire Kayahan; Huseyin Kadioglu; Mahmut Muslumanoglu
Journal:  Breast Care (Basel)       Date:  2012-06-27       Impact factor: 2.860

Review 4.  Treatments for Idiopathic Granulomatous Mastitis: Systematic Review and Meta-Analysis.

Authors:  Xin Lei; Kai Chen; Liling Zhu; Erwei Song; Fengxi Su; Shunrong Li
Journal:  Breastfeed Med       Date:  2017-07-21       Impact factor: 1.817

5.  Feasibility of surgical management in patients with granulomatous mastitis.

Authors:  Oktar Asoglu; Vahit Ozmen; Hasan Karanlik; Mehtap Tunaci; Neslihan Cabioglu; Abdullah Igci; Unal Ersin Selcuk; Mustafa Kecer
Journal:  Breast J       Date:  2005 Mar-Apr       Impact factor: 2.431

6.  Factors related to recurrence of idiopathic granulomatous mastitis: what do we learn from a multicentre study?

Authors:  Erdal Uysal; Atilla Soran; Efe Sezgin
Journal:  ANZ J Surg       Date:  2017-07-27       Impact factor: 1.872

7.  Idiopathic granulomatous mastitis: a 10-year study from a multicentre clinical database.

Authors:  Michael Co; Vincent C C Cheng; Jiannan Wei; Sally C Y Wong; Sally M S Chan; Tony Shek; Ava Kwong
Journal:  Pathology       Date:  2018-10-30       Impact factor: 5.306

8.  Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.

Authors:  Lili Pan; Juan Du; Taotao Li; Hua Liao
Journal:  BMJ Open       Date:  2017-05-04       Impact factor: 2.692

9.  Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea.

Authors:  Jeong Soo Lee; Na Young Kim; Se Hee Na; Young Hoon Youn; Cheung Soo Shin
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

10.  Scoring Idiopathic Granulomatous Mastitis: An Effective System for Predicting Recurrence?

Authors:  Tonguç Utku Yılmaz; Bora Gürel; Sertaç Ata Güler; Mehmet Ali Baran; Büşra Erşan; Seda Duman; Zafer Utkan
Journal:  Eur J Breast Health       Date:  2018-04-01
View more
  4 in total

1.  The Predictive Value of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio in Patients with Recurrent Idiopathic Granulomatous Mastitis.

Authors:  Sami Akbulut; Tevfik Tolga Şahin
Journal:  Eur J Breast Health       Date:  2020-07-01

Review 2.  Idiopathic granulomatous mastitis: introducing a diagnostic algorithm based on 5 years of follow-up of 152 cases from Turkey and a review of the literature.

Authors:  Mehmet Velidedeoglu; Veysel Umman; Fahrettin Kilic; Varol Celik; Ertugrul Gazioglu; Engin Hatipoglu; Tulin Ozturk; Birgul Mete
Journal:  Surg Today       Date:  2021-09-21       Impact factor: 2.549

3.  Risk Factors and the Role of the Albumin-to-Globulin Ratio in Predicting Recurrence Among Patients with Idiopathic Granulomatous Mastitis.

Authors:  Ahmet Burak Ciftci; Ömer Faruk Bük; Kürşat Yemez; Süleyman Polat; İrem Melike Yazıcıoğlu
Journal:  J Inflamm Res       Date:  2022-09-18

4.  Serum C-Reactive Protein and Interleukin-6 Levels as Biomarkers for Disease Severity and Clinical Outcomes in Patients with Idiopathic Granulomatous Mastitis.

Authors:  Yi-Min Huang; Chiao Lo; Chiao-Feng Cheng; Cheng-Hsun Lu; Song-Chou Hsieh; Ko-Jen Li
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.